Roche
ROG.SW
HK$2,529
Share price
-0.42%
Change (1 day)
0.52%
Change (1 year)
Categories
Operating Margin for Roche (ROG.SW)
Operating Margin at the end of 2024: 18.90%
According to Roche's latest financial reports and stock price the company's current Operating Margin is 18.90%. At the end of 2024 the company had an Operating Margin of 18.90%.
Operating Margin history for Roche from 2001 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 18.90% | -18.86% |
| 2023 | 23.29% | -6.1% |
| 2022 | 24.81% | -10.45% |
| 2021 | 27.70% | -10.06% |
| 2020 | 30.80% | 13.96% |
| 2019 | 27.03% | 8.6% |
| 2018 | 24.89% | 8.31% |
| 2017 | 22.98% | -10.65% |
| 2016 | 25.72% | 3.29% |
| 2015 | 24.90% | -5.58% |
| 2014 | 26.37% | -15.96% |
| 2013 | 31.37% | 17.4% |
| 2012 | 26.72% | -4.37% |
| 2011 | 27.94% | 18.33% |
| 2010 | 23.62% | 13.21% |
| 2009 | 20.86% | -32.8% |
| 2008 | 31.04% | -6.42% |
| 2007 | 33.17% | 10.8% |
| 2006 | 29.94% | 16.04% |
| 2005 | 25.80% | 15.56% |
| 2004 | 22.33% | 42.8% |
| 2003 | 15.63% | -244.17% |
| 2002 | -10.84% | -166.41% |
| 2001 | 16.33% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 18.78% | -0.63% | 🇺🇸 USA |
 Merck MRK | 31.06% | 64.34% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -33.33% | 🇺🇸 USA |
 Sanofi SNY | 15.12% | -20.00% | 🇫🇷 France |
 Novartis NVS | 28.02% | 48.25% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | 13.32% | -29.52% | 🇬🇧 UK |
 Abbott Laboratories ABT | 17.36% | -8.15% | 🇺🇸 USA |
 Amgen AMGN | 19.48% | 3.07% | 🇺🇸 USA |
 Becton Dickinson BDX | 8.06% | -57.35% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.